Jan Cerny to Polymerase Chain Reaction
This is a "connection" page, showing publications Jan Cerny has written about Polymerase Chain Reaction.
Connection Strength
0.412
-
Cerny J, Slavickova A, Krepelova A, Trneny M, Klener P. Chemotherapy alone may lead to a PCR negative stem cell harvest in transformed lymphoma refractory to rituximab. Haematologica. 2003 Mar; 88(3):ECR06.
Score: 0.187
-
Cerny J, Trneny M, Slavickova A, Pytlik R, Salkova J, Valkova V, Liu Q, Houghton J, Klener P. Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders. Hematology. 2009 Aug; 14(4):187-97.
Score: 0.073
-
Slav?ckov? A, Forsterov? K, Iv?nek R, Cern? J, Klener P. The use of comparative duplex PCR in monitoring of patients with non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Folia Biol (Praha). 2005; 51(6):177-9.
Score: 0.053
-
Cerny J, Slavickova A, Krepelova A, Trneny M, Karban J, Klener P. Biallelic IgH rearrangements in patients with indolent lymphoproliferative disorders: molecular and practical implications. J Cell Physiol. 2004 May; 199(2):217-26.
Score: 0.051
-
Cerny J, Slavickova A, Krepelova A, Trneny M, Karban J, Klener P. Unusual sequence of VDJ rearrangement revealed by molecular analysis in a patient with indolent lymphoma. Haematologica. 2003 May; 88(5):ECR15.
Score: 0.047